PL2501362T3 - Preparaty oczne oparte na BDNF (neurotroficzny czynnik pochodzenia mózgowego) i ich zastosowanie - Google Patents

Preparaty oczne oparte na BDNF (neurotroficzny czynnik pochodzenia mózgowego) i ich zastosowanie

Info

Publication number
PL2501362T3
PL2501362T3 PL10809037T PL10809037T PL2501362T3 PL 2501362 T3 PL2501362 T3 PL 2501362T3 PL 10809037 T PL10809037 T PL 10809037T PL 10809037 T PL10809037 T PL 10809037T PL 2501362 T3 PL2501362 T3 PL 2501362T3
Authority
PL
Poland
Prior art keywords
bdnf
brain
neurotrophic factor
derived neurotrophic
ophthalmic preparations
Prior art date
Application number
PL10809037T
Other languages
English (en)
Inventor
Luciano Domenici
Luca Giovannini
Marco Sanso'
Original Assignee
Hmfra Hungary Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42211955&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2501362(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hmfra Hungary Llc filed Critical Hmfra Hungary Llc
Publication of PL2501362T3 publication Critical patent/PL2501362T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Psychology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
PL10809037T 2009-11-16 2010-11-12 Preparaty oczne oparte na BDNF (neurotroficzny czynnik pochodzenia mózgowego) i ich zastosowanie PL2501362T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2009A002012A IT1396607B1 (it) 2009-11-16 2009-11-16 Preparazioni oftalmiche a base di bdnf (brain-derived neurotrophic factor) e loro uso.
EP10809037.4A EP2501362B1 (en) 2009-11-16 2010-11-12 Ophthalmic preparations based on bdnf (brain-derived neurotrophic factor) and their use
PCT/IB2010/003220 WO2011058449A2 (en) 2009-11-16 2010-11-12 Ophthalmic preparations based on bdnf (brain-derived neurotrophic factor) and their use

Publications (1)

Publication Number Publication Date
PL2501362T3 true PL2501362T3 (pl) 2015-02-27

Family

ID=42211955

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10809037T PL2501362T3 (pl) 2009-11-16 2010-11-12 Preparaty oczne oparte na BDNF (neurotroficzny czynnik pochodzenia mózgowego) i ich zastosowanie

Country Status (20)

Country Link
US (1) US9387164B2 (pl)
EP (1) EP2501362B1 (pl)
JP (2) JP2013510844A (pl)
KR (1) KR101831793B1 (pl)
CN (2) CN102639111A (pl)
BR (1) BR112012011542A2 (pl)
CA (1) CA2781008C (pl)
CL (1) CL2012001267A1 (pl)
CY (1) CY1115853T1 (pl)
DK (1) DK2501362T3 (pl)
ES (1) ES2524976T3 (pl)
HR (1) HRP20141129T1 (pl)
IT (1) IT1396607B1 (pl)
MX (1) MX341502B (pl)
PL (1) PL2501362T3 (pl)
PT (1) PT2501362E (pl)
RS (1) RS53687B1 (pl)
RU (1) RU2564920C2 (pl)
SI (1) SI2501362T1 (pl)
WO (1) WO2011058449A2 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201913468YA (en) * 2015-07-13 2020-03-30 Tohoku Techno Arch Co Ltd Composition for optic nerve protection
ITUA20162343A1 (it) * 2016-04-06 2017-10-06 Luciano Domenici Formulazioni intranasali di bdnf per uso nel trattamento di malattie neurodegenerative
CN111317814B (zh) * 2020-04-23 2020-12-18 中国中医科学院眼科医院 一种冰片联合神经营养因子组合物及应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283911B1 (it) * 1996-02-05 1998-05-07 Farmigea Spa Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
JPH10212241A (ja) 1996-05-27 1998-08-11 Sumitomo Pharmaceut Co Ltd Ｂｄｎｆを安定に含有する製剤
CN1233963A (zh) * 1996-09-13 1999-11-03 有限会社最先端医学研究所 神经营养因子的眼科用组合物、视神经机能障碍治疗药和视神经机能障碍治疗方法
IT1305294B1 (it) 1999-01-29 2001-05-04 Alessandro Lambiase Uso del nerve growth factor nella terapia di patologie a carico deitessuti intraoculari.
JP2003048851A (ja) * 2001-08-03 2003-02-21 Nidek Co Ltd 視細胞障害疾患治療薬
WO2006046584A1 (ja) 2004-10-26 2006-05-04 Santen Pharmaceutical Co., Ltd. 視細胞障害治療剤
US20070014760A1 (en) * 2005-07-18 2007-01-18 Peyman Gholam A Enhanced recovery following ocular surgery
WO2007101204A1 (en) * 2006-02-27 2007-09-07 Alcon Research, Ltd. Method of treating glaucoma
ITRM20070510A1 (it) * 2007-10-02 2009-04-03 Rmfa Trading S A Composizioni oftalmiche a base di polisaccaride del seme di tamarindo e acido ialuronico.

Also Published As

Publication number Publication date
JP2013510844A (ja) 2013-03-28
RU2012120096A (ru) 2013-11-20
US20120258916A1 (en) 2012-10-11
EP2501362A2 (en) 2012-09-26
WO2011058449A2 (en) 2011-05-19
SI2501362T1 (sl) 2014-12-31
CN102639111A (zh) 2012-08-15
KR20120101390A (ko) 2012-09-13
MX2012005624A (es) 2012-09-28
ITMI20092012A1 (it) 2011-05-17
PT2501362E (pt) 2014-12-04
US9387164B2 (en) 2016-07-12
HRP20141129T1 (hr) 2015-01-02
CN105769750A (zh) 2016-07-20
DK2501362T3 (en) 2014-11-17
RS53687B1 (en) 2015-04-30
CY1115853T1 (el) 2017-01-25
ES2524976T3 (es) 2014-12-16
EP2501362B1 (en) 2014-10-08
CA2781008A1 (en) 2011-05-19
KR101831793B1 (ko) 2018-02-23
MX341502B (es) 2016-08-22
IT1396607B1 (it) 2012-12-14
BR112012011542A2 (pt) 2016-06-28
RU2564920C2 (ru) 2015-10-10
WO2011058449A3 (en) 2011-12-01
JP2016026229A (ja) 2016-02-12
CA2781008C (en) 2018-02-06
CL2012001267A1 (es) 2012-12-07

Similar Documents

Publication Publication Date Title
SI2414363T1 (sl) Derivati 1-heterociklil-1,5-dihidro-pirazolo/3,4-d/pirimidin-4-ona in njihova uporaba kot modulatorji za PDE9A
IL215603A0 (en) Human protein scaffold with controlled serum pharmacokinetics, compositions comprising the same and uses thereof
HK1159108A1 (en) Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof
WO2009100255A3 (en) Modified leptin polypeptides and their uses
HK1151791A1 (en) Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
IL219888A0 (en) Pyridine-pyridinone derivatives, preparation and therapeutic use thereof
EP2600053A4 (en) LIGHTING AND DISPLAY DEVICES
IL201416A0 (en) Triazolopyridine carboxamide derivatives, preparation thereof and theraputic use thereof
EP2330910A4 (en) LEUCOJUM BULB EXTRACTS AND USE THEREOF
ZA201107363B (en) Quinazolinedione derivatives,preparation thereof and various therapeutic uses thereof
WO2011126882A9 (en) Therapeutic peptides and their derivatives and therapeutic uses thereof
IL207629A0 (en) Novel 3-aminoalkyl-1,3-dihydro-2h-indol-2-one derivatives, preparation thereof and therapeutic use thereof
HK1169387A1 (en) Pyrazole derivatives, their preparation and therapeutical use
GB2468604B (en) Stretcher with lifting mechanism and releasable securing means
EP2352477A4 (en) ARRANGEMENT IN CONNECTION WITH A MASSAGE DEVICE AND MASSAGE DEVICE
EP2246347A4 (en) DICYCLOAZAALKAN DERIVATIVES, METHOD OF MANUFACTURE AND MEDICAL APPLICATIONS THEREOF
SI2501362T1 (sl) Oftalmiäśni pripravki na osnovi bdnf (moĺ˝ganskega nevrotrofiäśnega faktorja) in njihova uporaba
HK1139671A1 (en) Azabicycloalkane derivatives, preparation thereof and use thereof in therapy
GB0905970D0 (en) Depsipeptides and their therapeutic use
HK1164861A1 (en) Substituted 3-benzofuranyl-indol-2-one-3-acetamidopiperazine derivatives, preparation thereof, and therapeutic use thereof
IL210529A0 (en) Substituted 1-benzyl-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof
HK1168750A1 (en) Method for neck care, and neck care kit comprising the method
SI2421864T1 (sl) 1-pirazolo(4,3-c)izokinolinski derivati, njihova priprava in njihova terapevtska uporaba
IL205987A0 (en) Bank1 splice variant, its preparation and use
EP2446633A4 (en) COLOR WHEEL UNIT AND PROJECTION SYSTEM THEREWITH